Skip to main content
Log in

Interindividual variability of coumarin 7-hydroxylation in a Turkish population

  • Pharmacoepidemiology And Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

One hundred healthy Turkish volunteers (70 male, 30 female) aged from 19 to 56 years were given 5 mg coumarin p.o. after an overnight fast. Urine samples were collected before and 2, 4 and 8 h after drug administration. The extent and rate of formation of 7-OH-coumarin (7OHC) was determined by the urinary excretion of the metabolite as measured with the fluorometric method.

On average, 80% of 7OHC formed was excreted in 2 h. The total amount of 7OHC formed was 59.8% (21.5%) (mean and SD, n=100, range 17–100%) of the given dose. The percentage of 7OHC excreted during the first 2 h compared with the 7OHC excretion at 8 h was a constant and stable individual characteristic for the rate of the formation of 7OHC (‘2 h coumarin test’).

Although four individuals had relatively slow coumarin test values (34–40%), no clear-cut polymorphism in the rate of 7OHC formation was found. However, 7OHC formation was lower in males and in cigarette smokers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD (1990) The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 22: 503–529

    Google Scholar 

  2. Moran E, O'Kennedy R, Thornes RD (1987) Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J Chromatogr 416: 165–169

    Google Scholar 

  3. Raunio H, Kojo A, Juvonen R, Honkakoski P, Jarvinen P, Lang MA, Vahakangas K, Gelboin HV, Park SS, Pelkonen O (1988) Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis 2-(3,5-dichloropyridyloxy) benzene, pyrazole, and phenobarbital. Biochem Pharmacol 37: 4141–4147

    Google Scholar 

  4. Nebert DW, Nelson DR, Coon MR, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, Gonzales FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ (1991) The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol 10: 1–14

    Google Scholar 

  5. Ritschel WA, Brady ME, Tan HSI, Hoffmann KA, Yiu IM, Grummich KW (1977) Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous administration of coumarin in man. Eur J Clin Pharmacol 12: 457–461

    Google Scholar 

  6. Ritschel WA, Brady ME, Tan HSI (1979) First-pass effect of coumarin in man. Int J Clin Pharmacol Biopharm 17: 99–103

    Google Scholar 

  7. Wood AW, Conney AH (1974) Genetic variation in coumarin hydroxylase activity in the mouse (Mus musculus). Science 185: 612–614

    Google Scholar 

  8. Lush IE, Andrews KM (1978) Genetic variation between mice in their metabolism of coumarin and its derivatives. Genet Res Camb 31: 177–186

    Google Scholar 

  9. Wood AW (1979) Genetic regulation of coumarin hydroxylase activity in mice. Biochemical characterization of the enzyme from two inbred strains and their F1 hybrid. J Biol Chem 254: 5641–5646

    Google Scholar 

  10. Lang MA, Juvonen R, Jarvinen P, Honkakoski P, Raunio H (1989) Mouse liver P450coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isozymes. Arch Biochem Biophys 271: 139–148

    Google Scholar 

  11. Pelkonen O, Sotaniemi EA, Ahokas JT (1985) Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br J Clin Pharmacol 19: 59–66

    Google Scholar 

  12. Miles JS, McLaren AW, Forrester LM, Glancey MJ, Lang MA, Wolf CR (1990) Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J 267: 365–371

    Google Scholar 

  13. Yamano S, Tatsuno HJ, Gonzales FJ (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29: 1322–1329

    Google Scholar 

  14. Rautio A, Holger K, Kojo A, Salmela E, Pelkonen O (1992) Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2: 227–233

    Google Scholar 

  15. Cholerton S, Idle ME, Vas A, Gonzales FJ, Idle JR (1992) Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. J Chromatogr 575: 325–330

    Google Scholar 

  16. Kalow W (1982) Ethnic differences in drug metabolism. Pharmacokinetics 7: 373–391

    Google Scholar 

  17. Negishi M, Lindberg R, Burkhart B, Ichikawa T, Honkakoski P, Lang M (1989) Mouse steroid 15α-hydroxylase gene family: identification of type II P-45015α as coumarin 7-hydroxylase. Biochemistry 28: 4169–4172

    Google Scholar 

  18. Maenpaa J (1993) Human P450 isoform assignment by antibodies and inhibitors PhD thesis (Acta Univ Oulu D 285), University of Oulu, Finland

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The scientific contents of this paper contribute to the goals of the COST B1 project.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iscan, M., Rostami, H., Güray, T. et al. Interindividual variability of coumarin 7-hydroxylation in a Turkish population. Eur J Clin Pharmacol 47, 315–318 (1994). https://doi.org/10.1007/BF00191161

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00191161

Key words

Navigation